Fieldpoint Private Securities’s Medifast MED Stock Holding History

Fieldpoint Private Securities’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	5	–	–	﹤0.01%	1364
2022 Q1	$1K	Hold	5	–	–	﹤0.01%	1587
2021 Q4	$1K	Hold	5	–	–	﹤0.01%	1580
2021 Q3	$1K	Hold	5	–	–	﹤0.01%	1582
2021 Q2	$1K	Hold	5	–	–	﹤0.01%	1493
2021 Q1	$1K	Hold	5	–	–	﹤0.01%	1490
2020 Q4	$1K	Buy	+5	New	+$884	﹤0.01%	1422

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.46B AUM 71.13% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Fieldpoint Private Securities's MED Position: Q2 2022 in Review

Fieldpoint Private Securities held its Medifast (MED) position steady in Q2 2022 at 5 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

Fieldpoint Private Securities first reported a position in MED in Q4 2020 and has held it in 7 quarters since. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

Fieldpoint Private Securities held 5 shares of Medifast worth $1K as of Q2 2022.
Fieldpoint Private Securities left its Medifast share count unchanged in Q2 2022.
Medifast made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1364 holding.
Fieldpoint Private Securities first reported a position in Medifast in Q4 2020 and has held it in 7 quarters since.
284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.